Mangoceuticals, Inc.MGRXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P60
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 20251.21%
Q2 202544.77%
Q1 2025-101.38%
Q4 20243.11%
Q3 202426.08%
Q2 2024-59.13%
Q1 202441.62%
Q4 20230.76%
Q3 20233.84%
Q2 20231.70%
Q1 2023-178.63%
Q4 2022-8.20%
Q3 2022-670.64%
Q2 2022-316.37%
Q1 2022-6.79%
Q4 20210.00%